[Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
Tugushi
O A
OA
Shliapuzhnikova
A V
AV
Listopadova
N A
NA
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005901:Glaucoma / Q000175:diagnosis / Q000188:drug therapy*; D015812:Glaucoma, Angle-Closure / Q000175:diagnosis / Q000188:drug therapy; D005902:Glaucoma, Open-Angle / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D000077338:Latanoprost; D008875:Middle Aged; D008916:Miotics / Q000008:administration & dosage / Q000627:therapeutic use*; D018721:Muscarinic Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D010862:Pilocarpine / Q000008:administration & dosage / Q000627:therapeutic use*; D011461:Prostaglandins F, Synthetic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011788:Quality of Life; D011795:Surveys and Questionnaires
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D008916:Miotics; D018721:Muscarinic Agonists; D011461:Prostaglandins F, Synthetic; D010862:Pilocarpine; D000077338:Latanoprost